Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013, Article ID 972347, 5 pages
http://dx.doi.org/10.1155/2013/972347
Clinical Study

Increased Serum ox-LDL Levels Correlated with Lung Function, Inflammation, and Oxidative Stress in COPD

Division of Pulmonary Diseases, State Key Laboratory of Biotherapy of China and Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu 610041, China

Received 27 April 2013; Revised 17 July 2013; Accepted 30 July 2013

Academic Editor: Ronit Shiri-Sverdlov

Copyright © 2013 Yongchun Shen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Vestbo, S. S. Hurd, A. G. Agustí et al., “Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary,” The American Journal of Respiratory and Critical Care Medicine, vol. 187, no. 4, pp. 347–365, 2013. View at Publisher · View at Google Scholar
  2. M. Decramer, W. Janssens, and M. Miravitlles, “Chronic obstructive pulmonary disease,” The Lancet, vol. 379, no. 9823, pp. 1341–1351, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. I. Rahman and I. M. Adcock, “Oxidative stress and redox regulation of lung inflammation in COPD,” European Respiratory Journal, vol. 28, no. 1, pp. 219–242, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Agustí, L. D. Edwards, S. I. Rennard et al., “Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype,” PLoS ONE, vol. 7, no. 5, Article ID e37482, 2012. View at Publisher · View at Google Scholar
  5. Z. L. Wang, “Evolving role of systemic inflammation in comorbidities of chronic obstructive pulmonary disease,” Chinese Medical Journal, vol. 123, no. 23, pp. 3467–3478, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Miller, L. D. Edwards, A. Agustí et al., “Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort,” Respiratory Medicine, 2013. View at Publisher · View at Google Scholar
  7. F. H. Greig, S. Kennedy, and C. M. Spickett, “Physiological effects of oxidized phospholipids and their cellular signaling mechanisms in inflammation,” Free Radical Biology and Medicine, vol. 52, no. 2, pp. 266–280, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Behnes, M. Brueckmann, V. Liebe et al., “Levels of oxidized low-density lipoproteins are increased in patients with severe sepsis,” Journal of Critical Care, vol. 23, no. 4, pp. 537–541, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Jin, Y. Zhao, W. Yan et al., “Elevated circulating interleukin-27 in patients with coronary artery disease is associated with dendritic cells, oxidized low-density lipoprotein, and severity of coronary artery stenosis,” Mediators of Inflammation, vol. 2012, Article ID 506283, 10 pages, 2012. View at Publisher · View at Google Scholar
  10. C. Mazière and J. C. Mazière, “Activation of transcription factors and gene expression by oxidized low-density lipoprotein,” Free Radical Biology and Medicine, vol. 46, no. 2, pp. 127–137, 2009. View at Publisher · View at Google Scholar
  11. J. B. Sedgwick, Y. S. Hwang, H. A. Gerbyshak, H. Kita, and W. W. Busse, “Oxidized low-density lipoprotein activates migration and degranulation of human granulocytes,” The American Journal of Respiratory Cell and Molecular Biology, vol. 29, no. 6, pp. 702–709, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. K. J. Min, K. H. Cho, and T. K. Kwon, “The effect of oxidized low density lipoprotein (oxLDL)-induced heme oxygenase-1 on LPS-induced inflammation in RAW 264.7 macrophage cells,” Cellular Signalling, vol. 24, no. 6, pp. 1215–1221, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. V. N. Bochkov and N. Leitinger, “Anti-inflammatory properties of lipid oxidation products,” Journal of Molecular Medicine, vol. 81, no. 10, pp. 613–626, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. J. W. Zmijewski, D. R. Moellering, C. Le Goffe, A. Landar, A. Ramachandran, and V. M. Darley-Usmar, “Oxidized LDL induces mitochondrially associated reactive oxygen/nitrogen species formation in endothelial cells,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 289, no. 2, pp. H852–H861, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. L. L. Guo, Y. J. Chen, T. Wang et al., “Ox-LDL-induced TGF-β1 production in human alveolar epithelial cells: involvement of the Ras/ERK/PLTP pathway,” Journal of Cellular Physiology, vol. 227, no. 9, pp. 3185–3191, 2012. View at Publisher · View at Google Scholar
  16. R. W. Dal Negro, M. Visconti, C. Micheletto, and S. Tognella, “Changes in blood ROS, e-NO, and some pro-inflammatory mediators in bronchial secretions following erdosteine or placebo: a controlled study in current smokers with mild COPD,” Pulmonary Pharmacology and Therapeutics, vol. 21, no. 2, pp. 304–308, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Karadag, S. Kirdar, A. B. Karul, and E. Ceylan, “The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease,” European Journal of Internal Medicine, vol. 19, no. 2, pp. 104–108, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Higashimoto, T. Iwata, M. Okada, H. Satoh, K. Fukuda, and Y. Tohda, “Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease,” Respiratory Medicine, vol. 103, no. 8, pp. 1231–1238, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Yamaguchi, J. Haginaka, S. Morimoto, Y. Fujioka, and M. Kunitomo, “Facilitated nitration and oxidation of LDL in cigarette smokers,” European Journal of Clinical Investigation, vol. 35, no. 3, pp. 186–193, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Ghoorah, A. de Soyza, and V. Kunadian, “Increased cardiovascular risk in patients with chronic obstructive pulmonary disease and the potential mechanisms linking the two conditions: a review,” Cardiology Review, vol. 21, no. 4, pp. 196–202, 2013. View at Publisher · View at Google Scholar
  21. P. Boschetto, B. Beghé, L. M. Fabbri, and C. Ceconi, “Link between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice,” Respirology, vol. 17, no. 3, pp. 422–431, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Tulek, A. S. Kivrak, S. Ozbek, F. Kanat, and M. Suerdem, “Phenotyping of chronic obstructive pulmonary disease using the modified Bhalla scoring system for high-resolution computed tomography,” Canadian Respiratory Journal, vol. 20, no. 2, pp. 91–96, 2013. View at Google Scholar